The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Decipher score as a predictor of response to treatment intensification in the NRG Oncology-RTOG 0534 (SPPORT) phase III randomized post-prostatectomy salvage radiotherapy trial.
 
Alan Pollack
No Relationships to Disclose
 
Marla Johnson
Employment - Veracyte
 
James Proudfoot
Employment - Veracyte
 
Elai Davicioni
Employment - Veracyte
Leadership - Veracyte
Stock and Other Ownership Interests - Veracyte
 
Alan Dal Pra
No Relationships to Disclose
 
Jeff Simko
Stock and Other Ownership Interests - Alpenglow biosciences; Protean Biodiagnostics; Triopsy Medical Inc.
Consulting or Advisory Role - Uro-1
Research Funding - Intuitive Surgical (Inst)
 
Andre-Guy Martin
Consulting or Advisory Role - Pfizer
Research Funding - TerSera (Inst)
 
Himanshu Lukka
No Relationships to Disclose
 
Steve Angyalfi
No Relationships to Disclose
 
Jeff Michalski
Leadership - American Society of Therapeutic Radiation Oncology
Travel, Accommodations, Expenses - American Society of Therapeutic Radiation Oncology
 
Marie Duclos
No Relationships to Disclose
 
George Rodrigues
No Relationships to Disclose
 
R. Lee
No Relationships to Disclose
 
Kevin Roof
No Relationships to Disclose
 
Angela Jia
Consulting or Advisory Role - Blue Earth Diagnostics; Myovant Sciences
Travel, Accommodations, Expenses - Myovant Sciences
 
Samantha Seaward
No Relationships to Disclose
 
Nader Khaouam
No Relationships to Disclose
 
Theodore Karrison
No Relationships to Disclose
 
Felix Feng
Stock and Other Ownership Interests - Artera; Bluestar Genomics; Serimmune
Consulting or Advisory Role - Artera; Astellas Pharma; Bayer; BlueStar Genomics; Bristol Myers Squibb; Bristol Myers Squibb (BMS); Exact Sciences; Foundation Medicine; Janssen Biotech; Myovant Sciences; Novartis; POINT Biopharma; Roivant; SerImmune; Tempus; Varian Medical Systems
Research Funding - Zenith Epigenetics
 
Phuoc Tran
Honoraria - Reflexion Medical
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer Health; Dendreon; GenomeDx; Janssen; Lantheus Medical Imaging; Myovant Sciences; Noxopharm; Reflexion Medical; Reflexion Medical; Regeneron
Research Funding - Astellas Pharma (Inst); Bayer Health (Inst); Reflexion Medical (Inst)
Patents, Royalties, Other Intellectual Property - Compounds and Methods of Use in Ablative Radiotherapy. Patent filed 3/9/2012. PCT/US2012/028475. PCT/WO/2012/122471.
Travel, Accommodations, Expenses - Reflexion Medical